Behavioral Health Market Research Reports & Industry Analysis

Mental Illness or psychotherapeutic conditions are classified as abnormal thoughts, feelings, and behavior, for a determined amount of time, which causes distress or emotional/physical impairment. This includes a wide range of psychological or psychiatric disorders and often requires psychiatric intervention. Conditions can be caused by either a biological origin such as genetic, chemical, and anatomical; or a psychological origin such as trauma or conflict.

Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders. Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behavior therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone.

The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.

...Show More ...Show Less


Behavioral Health Industry Research & Market Reports

  • Post-Traumatic Stress Disorder (PTSD) - Epidemiology Forecast to 2032

    ... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Post-Traumatic Stress Disorder ... Read More

  • Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2032

    ... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Bipolar Disorder (Manic ... Read More

  • Autism Spectrum Disorder (ASD) - Epidemiology Forecast to 2032

    ... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Autism Spectrum Disorder ... Read More

  • Global Depression Market and Competitive Landscape – 2017

    ... product forecasts, and market shares. This study accurately estimates and forecast Depression market size and drug sales. This research also provides insights into Depression epidemiology and late stage pipeline. The report is classified into twelve ... Read More

23 24 25 26 27 28 next >

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings